SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Simard J) "

Sökning: WFRF:(Simard J)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Jiang, Xia, et al. (författare)
  • Shared heritability and functional enrichment across six solid cancers
  • 2019
  • Ingår i: Nature Communications. - 2041-1723. ; 10
  • Tidskriftsartikel (refereegranskat)abstract
    • Quantifying the genetic correlation between cancers can provide important insights into the mechanisms driving cancer etiology. Using genome-wide association study summary statistics across six cancer types based on a total of 296,215 cases and 301,319 controls of European ancestry, here we estimate the pair-wise genetic correlations between breast, colorectal, head/neck, lung, ovary and prostate cancer, and between cancers and 38 other diseases. We observed statistically significant genetic correlations between lung and head/neck cancer (rg = 0.57, p = 4.6 × 10−8), breast and ovarian cancer (rg = 0.24, p = 7 × 10−5), breast and lung cancer (rg = 0.18, p =1.5 × 10−6) and breast and colorectal cancer (rg = 0.15, p = 1.1 × 10−4). We also found that multiple cancers are genetically correlated with non-cancer traits including smoking, psychiatric diseases and metabolic characteristics. Functional enrichment analysis revealed a significant excess contribution of conserved and regulatory regions to cancer heritability. Our comprehensive analysis of cross-cancer heritability suggests that solid tumors arising across tissues share in part a common germline genetic basis. © 2019, The Author(s).
2.
  • Abdallah, J., et al. (författare)
  • Measurement of the mass and width of the W boson in e(+) e(-) collisions at root s=161-209 GeV
  • 2008
  • Ingår i: European Physical Journal C. Particles and Fields. - Springer. - 1434-6044. ; 55:1, s. 1-38
  • Tidskriftsartikel (refereegranskat)abstract
    • A measurement of the W boson mass and width has been performed by the DELPHI collaboration using the data collected during the full LEP2 programme (1996-2000). The data sample has an integrated luminosity of 660 pb(-1) and was collected over a range of centre-of-mass energies from 161 to 209 GeV. Results are obtained by applying the method of direct reconstruction of the mass of the W from its decay products in both the W+W- -> l (nu) over bar (l) and W+W- -> q (q) over bar'(q) over barq'channels. The W mass result for the combined data set is M-W = 80.336 +/- 0.055(Stat.) +/- 0.028(Syst.) +/- 0.025(FSI) +/- 0.009(LEP) GeV/c(2) , where FSI represents the uncertainty due to final state interaction effects in the q (q) over bar'(q) over barq' channel, and LEP represents that arising from the knowledge of the collision energy of the accelerator. The combined value for the W width is Gamma(W) = 2.404 +/- 0.140(Stat.) +/- 0.077(Syst.) +/- 0.065(FSI) GeV/c(2). These results supersede all values previously published by the DELPHI collaboration.
  •  
3.
  • Abdallah, J., et al. (författare)
  • Measurement of the mass and width of the W boson in e(+) e(-) collisions at root s=161-209 GeV
  • 2008
  • Ingår i: European Physical Journal C. - 1434-6044 .- 1434-6052. ; 55:1, s. 1-38
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>A measurement of the W boson mass and width has been performed by the DELPHI collaboration using the data collected during the full LEP2 programme (1996-2000). The data sample has an integrated luminosity of 660 pb(-1) and was collected over a range of centre-of-mass energies from 161 to 209 GeV. Results are obtained by applying the method of direct reconstruction of the mass of the W from its decay products in both the W+W- -&gt; l (nu) over bar (l) and W+W- -&gt; q (q) over bar'(q) over barq'channels. The W mass result for the combined data set is M-W = 80.336 +/- 0.055(Stat.) +/- 0.028(Syst.) +/- 0.025(FSI) +/- 0.009(LEP) GeV/c(2) , where FSI represents the uncertainty due to final state interaction effects in the q (q) over bar'(q) over barq' channel, and LEP represents that arising from the knowledge of the collision energy of the accelerator. The combined value for the W width is Gamma(W) = 2.404 +/- 0.140(Stat.) +/- 0.077(Syst.) +/- 0.065(FSI) GeV/c(2). These results supersede all values previously published by the DELPHI collaboration.</p>
  •  
4.
  • Ferreira, Manuel A., et al. (författare)
  • Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
  • 2019
  • Ingår i: Nature communications. - 2041-1723. ; 10:1, s. 1741
  • Tidskriftsartikel (refereegranskat)abstract
    • Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer. © 2019, The Author(s).
5.
  •  
6.
  • Fachal, Laura, et al. (författare)
  • Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
  • 2020
  • Ingår i: Nature genetics. - 1546-1718. ; 52:1, s. 56-73
  • Tidskriftsartikel (refereegranskat)abstract
    • Genome-wide association studies have identified breast cancer risk variants in over 150 genomic regions, but the mechanisms underlying risk remain largely unknown. These regions were explored by combining association analysis with in silico genomic feature annotations. We defined 205 independent risk-associated signals with the set of credible causal variants in each one. In parallel, we used a Bayesian approach (PAINTOR) that combines genetic association, linkage disequilibrium and enriched genomic features to determine variants with high posterior probabilities of being causal. Potentially causal variants were significantly over-represented in active gene regulatory regions and transcription factor binding sites. We applied our INQUSIT pipeline for prioritizing genes as targets of those potentially causal variants, using gene expression (expression quantitative trait loci), chromatin interaction and functional annotations. Known cancer drivers, transcription factors and genes in the developmental, apoptosis, immune system and DNA integrity checkpoint gene ontology pathways were over-represented among the highest-confidence target genes.
  •  
7.
  • Kuchenbaecker, Karoline B, et al. (författare)
  • Identification of six new susceptibility loci for invasive epithelial ovarian cancer
  • 2015
  • Ingår i: Nature genetics. - 1546-1718. ; 47:2, s. 164-171
  • Tidskriftsartikel (refereegranskat)abstract
    • Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibility alleles. The pattern of association at these loci is consistent in BRCA1 and BRCA2 mutation carriers who are at high risk of EOC. After imputation to 1000 Genomes Project data, we assessed associations of 11 million genetic variants with EOC risk from 15,437 cases unselected for family history and 30,845 controls and from 15,252 BRCA1 mutation carriers and 8,211 BRCA2 mutation carriers (3,096 with ovarian cancer), and we combined the results in a meta-analysis. This new study design yielded increased statistical power, leading to the discovery of six new EOC susceptibility loci. Variants at 1p36 (nearest gene, WNT4), 4q26 (SYNPO2), 9q34.2 (ABO) and 17q11.2 (ATAD5) were associated with EOC risk, and at 1p34.3 (RSPO1) and 6p22.1 (GPX6) variants were specifically associated with the serous EOC subtype, all with P < 5 × 10(-8). Incorporating these variants into risk assessment tools will improve clinical risk predictions for BRCA1 and BRCA2 mutation carriers.
  •  
8.
  • Rebbeck, Timothy R., et al. (författare)
  • Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
  • ????
  • Ingår i: Human Mutation. - John Wiley and Sons Inc.. - 1059-7794.
  • Tidskriftsartikel (refereegranskat)abstract
    • The prevalence and spectrum of germline mutations in BRCA1 and BRCA2 have been reported in single populations, with the majority of reports focused on White in Europe and North America. The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) has assembled data on 18,435 families with BRCA1 mutations and 11,351 families with BRCA2 mutations ascertained from 69 centers in 49 countries on six continents. This study comprehensively describes the characteristics of the 1,650 unique BRCA1 and 1,731 unique BRCA2 deleterious (disease-associated) mutations identified in the CIMBA database. We observed substantial variation in mutation type and frequency by geographical region and race/ethnicity. In addition to known founder mutations, mutations of relatively high frequency were identified in specific racial/ethnic or geographic groups that may reflect founder mutations and which could be used in targeted (panel) first pass genotyping for specific populations. Knowledge of the population-specific mutational spectrum in BRCA1 and BRCA2 could inform efficient strategies for genetic testing and may justify a more broad-based oncogenetic testing in some populations.
  •  
9.
  •  
10.
  • Figlioli, G, et al. (författare)
  • The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
  • 2019
  • Ingår i: NPJ breast cancer. - 2374-4677. ; 5, s. 38
  • Tidskriftsartikel (refereegranskat)abstract
    • Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM−/− patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors. © 2019, The Author(s).
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (52)
Typ av publikation
tidskriftsartikel (209)
konferensbidrag (2)
Typ av innehåll
refereegranskat (198)
övrigt vetenskapligt (14)
Författare/redaktör
Simard, J (100)
Hamann, U (93)
Benitez, J. (89)
Simard, Jacques (85)
Nevanlinna, H (83)
Easton, DF (78)
visa fler...
Peterlongo, P (77)
Radice, P (77)
Meindl, A (77)
Benitez, Javier (77)
Andrulis, IL (76)
Chenevix-Trench, G (76)
Jakubowska, A (75)
Hamann, Ute (75)
Couch, FJ (74)
Lubinski, J (74)
Easton, Douglas F. (74)
Nevanlinna, Heli (73)
Andrulis, Irene L. (73)
Radice, Paolo (73)
Meindl, Alfons (70)
Chenevix-Trench, Geo ... (70)
Neuhausen, Susan L (66)
Hopper, JL (66)
Devilee, P (66)
Schmutzler, RK (66)
Peterlongo, Paolo (66)
Chang-Claude, J (65)
Southey, MC (64)
Antoniou, Antonis C. (64)
McGuffog, Lesley (64)
Lubinski, Jan (64)
Hall, P, (63)
Offit, Kenneth (63)
Dennis, J (62)
Fasching, PA (62)
Osorio, Ana (62)
Giles, GG (61)
Garcia-Closas, M (61)
Thomassen, Mads (61)
Caldes, Trinidad (61)
Neuhausen, SL (60)
Dunning, AM (60)
Guenel, P (60)
Czene, K, (59)
Schmidt, MK (59)
Stoppa-Lyonnet, Domi ... (59)
Montagna, Marco (59)
BRENNER, H (58)
Jakubowska, Anna (58)
visa färre...
Lärosäte
Karolinska Institutet (140)
Lunds universitet (73)
Uppsala universitet (27)
Linköpings universitet (14)
Umeå universitet (13)
Göteborgs universitet (8)
visa fler...
Jönköping University (4)
Örebro universitet (3)
Stockholms universitet (1)
visa färre...
Språk
Engelska (209)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (131)
Naturvetenskap (5)
Teknik (1)
Samhällsvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy